Nationally and internationally renowned faculty provides a state-of-the-art update on the latest treatment options for patients with hepato-biliary and pancreatic cancers. The program is designed to provide a multidisciplinary overview on the importance of early diagnosis and treatment considerations, including surgery and new pharmacological agents, and how to incorporate these into clinical practice. There will also be a focus on emerging immuno-oncology and molecular profiling options.
This event offers
14.5 CME credits
CE accredited by In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team..
Interested In Attending This Event?
Additional Registration Information:
Registration Fee (in USD)
MD, PhD, DO
On or before September 26, 2018 - $385
After September 26, 2018 - $460
RN, PA, NP, Other
On or before September 26, 2018 - $310
After September 26, 2018 - $385
Comprehensive program schedule and registration available at: ce.mayo.edu/CANCERMGMT2018